QQQ   445.99 (+1.59%)
AAPL   179.96 (-0.44%)
MSFT   415.09 (+0.35%)
META   502.60 (+2.54%)
GOOGL   138.05 (-0.30%)
AMZN   178.49 (+0.98%)
TSLA   203.04 (+0.57%)
NVDA   820.92 (+3.77%)
NIO   5.81 (+1.04%)
AMD   201.11 (+4.46%)
BABA   74.75 (+0.97%)
T   16.98 (+0.30%)
F   12.42 (-0.16%)
MU   95.72 (+5.64%)
CGC   3.22 (-2.13%)
GE   159.03 (+1.36%)
DIS   111.90 (+0.29%)
AMC   4.39 (+1.62%)
PFE   26.61 (+0.19%)
PYPL   60.72 (+0.63%)
XOM   105.75 (+1.18%)
QQQ   445.99 (+1.59%)
AAPL   179.96 (-0.44%)
MSFT   415.09 (+0.35%)
META   502.60 (+2.54%)
GOOGL   138.05 (-0.30%)
AMZN   178.49 (+0.98%)
TSLA   203.04 (+0.57%)
NVDA   820.92 (+3.77%)
NIO   5.81 (+1.04%)
AMD   201.11 (+4.46%)
BABA   74.75 (+0.97%)
T   16.98 (+0.30%)
F   12.42 (-0.16%)
MU   95.72 (+5.64%)
CGC   3.22 (-2.13%)
GE   159.03 (+1.36%)
DIS   111.90 (+0.29%)
AMC   4.39 (+1.62%)
PFE   26.61 (+0.19%)
PYPL   60.72 (+0.63%)
XOM   105.75 (+1.18%)
QQQ   445.99 (+1.59%)
AAPL   179.96 (-0.44%)
MSFT   415.09 (+0.35%)
META   502.60 (+2.54%)
GOOGL   138.05 (-0.30%)
AMZN   178.49 (+0.98%)
TSLA   203.04 (+0.57%)
NVDA   820.92 (+3.77%)
NIO   5.81 (+1.04%)
AMD   201.11 (+4.46%)
BABA   74.75 (+0.97%)
T   16.98 (+0.30%)
F   12.42 (-0.16%)
MU   95.72 (+5.64%)
CGC   3.22 (-2.13%)
GE   159.03 (+1.36%)
DIS   111.90 (+0.29%)
AMC   4.39 (+1.62%)
PFE   26.61 (+0.19%)
PYPL   60.72 (+0.63%)
XOM   105.75 (+1.18%)
QQQ   445.99 (+1.59%)
AAPL   179.96 (-0.44%)
MSFT   415.09 (+0.35%)
META   502.60 (+2.54%)
GOOGL   138.05 (-0.30%)
AMZN   178.49 (+0.98%)
TSLA   203.04 (+0.57%)
NVDA   820.92 (+3.77%)
NIO   5.81 (+1.04%)
AMD   201.11 (+4.46%)
BABA   74.75 (+0.97%)
T   16.98 (+0.30%)
F   12.42 (-0.16%)
MU   95.72 (+5.64%)
CGC   3.22 (-2.13%)
GE   159.03 (+1.36%)
DIS   111.90 (+0.29%)
AMC   4.39 (+1.62%)
PFE   26.61 (+0.19%)
PYPL   60.72 (+0.63%)
XOM   105.75 (+1.18%)

8 Pharmaceutical Companies Working on a Coronavirus Cure

 
We are living through interesting times. Not an hour goes by when Americans don’t receive some reminder of the impact the coronavirus has on our lives. The race is on for an effective, FDA-approved treatment for the virus. Despite, vaccines being available for human trial in record time, we are many months away from having a viable vaccine.

However, we may be somewhat closer in finding some antiviral treatments. And if you’ve watched the market closely this week, any news on that front tends to move the market in a positive direction.

That brings up another truth of investing. There are some stocks that thrive from other stocks misery. And that’s why we’ve put together this special report. If you’re an investor who is looking to jump into this bear market, the pharmaceutical sector is a logical choice.

A combination of big-name drug companies as well as smaller startup companies are working around the clock to develop vaccines or treatments that will target the infection caused by the novel coronavirus.

Click the "Continue to Slide #1" button to view the first company.